BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17673075)

  • 1. Intrapleural fibrinolytics for pleural infection: optimizing dosing for future trials.
    Heppler JS
    Mayo Clin Proc; 2007 Aug; 82(8):1016; author reply 1016-7. PubMed ID: 17673075
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
    Levinson GM; Pennington DW
    Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic approaches to pleural infection.
    Corcoran JP; Hallifax R; Rahman NM
    Curr Opin Infect Dis; 2013 Apr; 26(2):196-202. PubMed ID: 23286936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
    Muhammad Redzwan SRA
    Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy.
    Ben-Or S; Feins RH; Veeramachaneni NK; Haithcock BE
    Ann Thorac Surg; 2011 Mar; 91(3):860-3; discussion 863-4. PubMed ID: 21353015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of parapneumonic effusions and empyema.
    Psallidas I; Corcoran JP; Rahman NM
    Semin Respir Crit Care Med; 2014 Dec; 35(6):715-22. PubMed ID: 25463162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural agents for pleural infection: fibrinolytics and beyond.
    Rahman NM
    Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural fibrinolytics for pleural infection: partial answers in the discussion of surgical vs nonsurgical treatment.
    Deschamps C
    Mayo Clin Proc; 2007 Apr; 82(4):405-6. PubMed ID: 17418066
    [No Abstract]   [Full Text] [Related]  

  • 9. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTS guidelines for the management of pleural infection.
    Davies CW; Gleeson FV; Davies RJ;
    Thorax; 2003 May; 58 Suppl 2(Suppl 2):ii18-28. PubMed ID: 12728147
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
    Biswas A; Jantz MA; Barnes MD; Mehta HJ
    J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrapleural alteplase therapy: what are the knowns and unknowns?
    Staša J; Gregorová J; Pauk N
    Cas Lek Cesk; 2019; 158(7-8):295-299. PubMed ID: 31995996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
    Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
    Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.
    McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR
    Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural alteplase in a patient with complicated pleural effusion.
    Walker CA; Shirk MB; Tschampel MM; Visconti JA
    Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome and long-term survival in patients with pleural infection.
    Davies CW; Kearney SE; Gleeson FV; Davies RJ
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1682-7. PubMed ID: 10556140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
    Gilbert CR; Gorden JA
    Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of fibrinolytics and deoxyribonuclease in patients with pleural infection].
    Zhao ZW; Shi HZ
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2343-2345. PubMed ID: 34404122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.